Replies to post #3767 on Biotech Values

[DewDiligence]

Yes, the usual suspects.

Nice trade on AGIX. I consider myself a little weak in the cardio area and hence I don’t tread there too often. NTMD was an exception.

[DewDiligence]

Another thought about AGIX: I wonder how much of today’s AH pop came from the Esperion coattails; i.e. AGIX investors’ hoping that lightning would strike twice. The data per se do not seem to be fully consistent with the now-ample market cap of the stock.